Education

Automation-assisted cytology no better than conventional screening

Hot on the heels of the MAVARIC trial showing no benefit of automation-assisted cervical cytology, a large RCT from Finland involving more than half a million cases has reached the same conclusion.



http://onlinelibrary.wiley.com/doi/10.1002/ijc.25677/abstract

Downloads